Cargando…

Integrating newborn screening for spinal muscular atrophy into health care systems: an Australian pilot programme

AIM: This study dynamically designed, evaluated, and implemented the components of an Australian newborn bloodspot screening (NBS) pilot programme for spinal muscular atrophy (SMA). METHOD: We used an implementation‐effectiveness study design and continuous interdisciplinary review to measure SMA NB...

Descripción completa

Detalles Bibliográficos
Autores principales:	D'Silva, Arlene M, Kariyawasam, Didu S T, Best, Stephanie, Wiley, Veronica, Farrar, Michelle A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299803/ https://www.ncbi.nlm.nih.gov/pubmed/34839535 http://dx.doi.org/10.1111/dmcn.15117

Ejemplares similares

“We needed this”: perspectives of parents and healthcare professionals involved in a pilot newborn screening program for spinal muscular atrophy
por: Kariyawasam, Didu S.T., et al.
Publicado: (2021)

Biomarkers and the Development of a Personalized Medicine Approach in Spinal Muscular Atrophy
por: Kariyawasam, Didu S. T., et al.
Publicado: (2019)

Identification of Novel CSF-Derived miRNAs in Treated Paediatric Onset Spinal Muscular Atrophy: An Exploratory Study
por: D’Silva, Arlene M., et al.
Publicado: (2023)

Motor unit changes in children with symptomatic spinal muscular atrophy treated with nusinersen
por: Kariyawasam, Didu, et al.
Publicado: (2021)

Onasemnogene abeparvovec in spinal muscular atrophy: an Australian experience of safety and efficacy
por: D'Silva, Arlene M., et al.
Publicado: (2022)

Incidence of Duchenne muscular dystrophy in the modern era; an Australian study
por: Kariyawasam, Didu, et al.
Publicado: (2022)

Newborn Screening for the Diagnosis and Treatment of Duchenne Muscular Dystrophy: First Workshop Report: Establishing Australian health system readiness for the implementation and evaluation of a pilot program in New South Wales and the Australian Capital Territory
por: Farrar, Michelle A., et al.
Publicado: (2023)

Gene therapy-based strategies for spinal muscular atrophy—an Asia-Pacific perspective
por: Farrar, Michelle A., et al.
Publicado: (2023)

Modelling the Cost-Effectiveness and Budget Impact of a Newborn Screening Program for Spinal Muscular Atrophy and Severe Combined Immunodeficiency
por: Shih, Sophy T. F., et al.
Publicado: (2022)

Spinal Muscular Atrophy Diagnosed by Newborn Screening
por: Lopez-Chacon, Matias, et al.
Publicado: (2019)

“Getting ready for the adult world”: how adults with spinal muscular atrophy perceive and experience healthcare, transition and well-being
por: Wan, Hamish W. Y., et al.
Publicado: (2019)

Interventions for spinal muscular atrophy: an impetus for newborn screening
Publicado: (2021)

A Novel System for Spinal Muscular Atrophy Screening in Newborns: Japanese Pilot Study
por: Shinohara, Masakazu, et al.
Publicado: (2019)

Pilot Program of Newborn Screening for 5q Spinal Muscular Atrophy in the Russian Federation
por: Mikhalchuk, Kristina, et al.
Publicado: (2023)

A Voluntary Statewide Newborn Screening Pilot for Spinal Muscular Atrophy: Results from Early Check
por: Kucera, Katerina S., et al.
Publicado: (2021)

Advances in Newborn Screening and Presymptomatic Diagnosis of Spinal Muscular Atrophy
por: Jędrzejowska, Maria
Publicado: (2020)

Spinal Muscular Atrophy: Diagnosis, Incidence, and Newborn Screening in Japan
por: Kimizu, Tomokazu, et al.
Publicado: (2021)

Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in England
por: Weidlich, Diana, et al.
Publicado: (2023)

Alberta Spinal Muscular Atrophy Newborn Screening—Results from Year 1 Pilot Project
por: Niri, Farshad, et al.
Publicado: (2023)

Financial, opportunity and psychosocial costs of spinal muscular atrophy: an exploratory qualitative analysis of Australian carer perspectives
por: Farrar, Michelle A, et al.
Publicado: (2018)

Newborn screening for spinal muscular atrophy: The views of affected families and adults
por: Boardman, Felicity K., et al.
Publicado: (2017)

Views of the General Population on Newborn Screening for Spinal Muscular Atrophy in Japan
por: Lee, Tomoko, et al.
Publicado: (2021)

Massachusetts’ Findings from Statewide Newborn Screening for Spinal Muscular Atrophy
por: Hale, Jaime E., et al.
Publicado: (2021)

Newborn screening for spinal muscular atrophy in Japan: One year of experience
por: Sawada, Takaaki, et al.
Publicado: (2022)

Three years pilot of spinal muscular atrophy newborn screening turned into official program in Southern Belgium
por: Boemer, François, et al.
Publicado: (2021)

Emerging therapies and challenges in spinal muscular atrophy
por: Farrar, Michelle A., et al.
Publicado: (2017)

Newborn genetic screening for spinal muscular atrophy in the UK: The views of the general population
por: Boardman, Felicity K., et al.
Publicado: (2017)

Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening
por: Glascock, Jacqueline, et al.
Publicado: (2018)

Newborn Screening for Spinal Muscular Atrophy in China Using DNA Mass Spectrometry
por: Lin, Yiming, et al.
Publicado: (2019)

A call to introduce newborn screening for spinal muscular atrophy (SMA) in Scotland
por: Gillingwater, Thomas H., et al.
Publicado: (2022)

Landscape of Spinal Muscular Atrophy Newborn Screening in the United States: 2018–2021
por: Hale, Kshea, et al.
Publicado: (2021)

Neurological assessment of newborns with spinal muscular atrophy identified through neonatal screening
por: Pane, Marika, et al.
Publicado: (2022)

The Carrier Frequency of Two SMN1 Genes in Parents of Symptomatic Children with SMA and the Significance of SMN1 Exon 8 in Carriers
por: Davidson, Joanne E, et al.
Publicado: (2023)

Newborn screening for spinal muscular atrophy in Germany: clinical results after 2 years
por: Vill, Katharina, et al.
Publicado: (2021)

Technical feasibility of newborn screening for spinal muscular atrophy by next-generation DNA sequencing
por: Shum, Bennett O. V., et al.
Publicado: (2023)

PCR-Based Screening of Spinal Muscular Atrophy for Newborn Infants in Hyogo Prefecture, Japan
por: Noguchi, Yoriko, et al.
Publicado: (2022)

Spinal Muscular Atrophy Treatment in Patients Identified by Newborn Screening—A Systematic Review
por: Aragon-Gawinska, Karolina, et al.
Publicado: (2023)

Inherited Paediatric Motor Neuron Disorders: Beyond Spinal Muscular Atrophy
por: Teoh, Hooi Ling, et al.
Publicado: (2017)

Longitudinal developmental profile of newborns and toddlers treated for spinal muscular atrophy
por: Ngawa, Magali, et al.
Publicado: (2023)

Understanding the ongoing learning needs of Australian paediatricians: Evaluation of a pilot paediatric video teaching programme
por: Le Marne, Fleur A, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jl2qf2ntj50iu380otbl7ulqk7